Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer
Biomolecules and Biomedicine · 2025
DOI: 10.17305/bb.2025.12028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Pengcheng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospita…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Immunogenic Cell Death. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunogenic cell death (ICD) reshapes the tumor immune microenvironment and activates the adaptive immune response. However, the clinical significance of ICD-associated genes in colorectal cancer (CRC) remains unclear. In this study, we used weighted gene co-expression network analysis (WGCNA) to identify ICD-related gene modules. An ICD-related risk score (ICDRS) was then constructed using Cox regression modeling and LASSO analysis. Immune cell infiltration in patients with different risk levels was assessed using the ESTIMATE and single-sample Gene Set Enrichment Analysis algorithms (GSEA). The oncoPredict package was employed to explore the association between the ICDRS and chemotherapy drug sensitivity. Finally, the expression levels of ICD-related genes were validated through in vitro cellular experiments. Three CRC prognostic genes—CLMP, Neuropilin-1 (NRP1), and PLEKHO1—were identified from a set of 34 ICD-associated genes based on WGCNA and LASSO analyses. These genes were used to construct the ICDRS model. Notably, a high ICDRS was found to be an independent predictor of poorer overall survival (OS) in CRC patients. High-risk patients also exhibited increased immune cell infiltration. Moreover, the ICDRS was significantly correlated with sensitivity to conventional chemotherapeutic drugs, suggesting its potential utility in guiding personalized chemotherapy. Cellular assays confirmed that CLMP, NRP1, and PLEKHO1 were differentially expressed between normal and cancerous cells, and that NRP1 specifically promoted the proliferation, migration, and invasion of CRC cells. In conclusion, the ICDRS may serve as a reliable predictor of CRC prognosis and offers a promising direction for the clinical management of CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Colorectal Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Colorectal and Anal Surgery, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Tai…
Zitieren
APA
Wang, P., Zhao, W., Guo, L., & Cao, H. (2025). Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2025.12028
Vancouver
Wang P, Zhao W, Guo L, Cao H. Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2025.12028
BibTeX
@article{Wang2025,
author = {Wang, Pengcheng and Zhao, Wei and Guo, Linghong and Cao, Hailei},
title = {Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer},
journal = {Biomolecules and Biomedicine},
year = {2025},
doi = {10.17305/bb.2025.12028}
}
EUVIMED